# Hôpital Habib Bourguiba, Sfax

Source: https://onco.cc/institutions/chu-habib-bourguiba-sfax/  
OnCo record `chu-habib-bourguiba-sfax` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A hospital in Sfax, in southern Tunisia, whose radiotherapy department has two linear accelerators, a cobalt unit and two brachytherapy units. It is a site for an international breast cancer trial.

## Summary

IAEA DIRAC's equipment report, read on 11 November 2026 with the entry last updated in 2024, lists Habib Bourguiba Hospital in Sfax with two linear accelerators, one cobalt-60 unit, two brachytherapy units and a CT scanner. ClinicalTrials.gov lists Habib Bourguiba Hospital, Sfax, as a site of the trial of inavolisib with pertuzumab and trastuzumab in PIK3CA-mutated HER2-positive breast cancer (NCT05894239). OnCo could not read a site of the hospital's own.

## Fields

- Kind: Institution
- Last checked: 2026-11-11
- Also known as: Habib Bourguiba Hospital, Sfax; CHU Habib Bourguiba Sfax
- City: Sfax, TN
- Type: hospital

## Sources

- IAEA DIRAC: radiotherapy centres and equipment (read 11 November 2026): https://dirac.iaea.org/Data/CountriesLight
- ClinicalTrials.gov NCT05894239: site list: https://clinicaltrials.gov/study/NCT05894239

## Connected records

- cancers: [Breast cancer (all types)](https://onco.cc/cancers/breast-cancer/)
- institutions: [Centre Hospitalier Universitaire Farhat Hached, Sousse](https://onco.cc/institutions/chu-farhat-hached-sousse/), [Institut Salah Azaïez](https://onco.cc/institutions/institut-salah-azaiez/)
- trials: [A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer](https://onco.cc/trials/nct05894239/)

---
JSON: https://onco.cc/api/v1/entities/chu-habib-bourguiba-sfax.json